Text Size

Gender-Responsive Treatment for Women Offenders - 1

This study is currently recruiting participants.
Verified March 2013 by University of California, Los Angeles
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Michael Prendergast, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00249613
First received: November 3, 2005
Last updated: March 4, 2013
Last verified: March 2013
History of Changes
  Purpose

The purpose of this study is to determine whether substance abuse treatment designed specifically for drug-dependent women offenders provides better outcomes than standard drug court treatment (mixed-gender programs).


Condition Intervention Phase
Outpatient Treatment
Substance Dependence
 Behavioral: Outpatient Treatment
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Gender-Responsive Treatment for Women Offenders

Further study details as provided by University of California, Los Angeles:

Primary Outcome Measures:
  • Arrests/jail
  • Psychiatric symptoms
  • Substance use and retention

Secondary Outcome Measures:
  • Employment

Estimated Enrollment: 300
Study Start Date: June 2005
Detailed Description:

In this five-year study, a total of 300 women entering court-referred treatment throughout Los Angeles County and who agree to participate in the study will be randomly assigned to a women-focused or to a mixed-gender outpatient treatment program. The study will assess the impact of women-focused substance abuse treatment using outcome measures including recidivism, substance abuse and relapse, and social adjustment (e.g., employment, parenting behaviors, psychological improvement, and HIV risk reduction behaviors), compared to the impact of traditional mixed-gender programs. Assessments will occur at baseline and at 1 month, 12 months, and 24 months after admission.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Drug court participant
  • At least eighteen (18) years old
  • Have had no more than three prior non-violent, non-drug felony convictions
  • Do not have a current charge of driving under the influence of alcohol or drugs or a charge of sale or transportation of drugs

Exclusion Criteria:

  • Not capable of giving informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00249613

Contacts
Contact: Elizabeth Hall, Ph.D. (310)445-0874 ext 332 ehall@ucla.edu

Locations
United States, California
University of California - Los Angeles Recruiting
Los Angeles, California, United States, 90024
Contact: Elizabeth Hall, Ph.D.     310-312-0500 ext 532     ehall@ucla.edu    
Sponsors and Collaborators
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Michael Prendergast, Ph.D. University of California, Los Angeles
  More Information

No publications provided

Responsible Party: Michael Prendergast, Research Historian, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT00249613     History of Changes
Other Study ID Numbers: NIDA-16277-1, R01DA016277, R01-16277-1
Study First Received: November 3, 2005
Last Updated: March 4, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 22, 2013